Review



inactive analogue kn 92 phosphate  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress inactive analogue kn 92 phosphate
    Inactive Analogue Kn 92 Phosphate, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/inactive analogue kn 92 phosphate/product/MedChemExpress
    Average 94 stars, based on 11 article reviews
    inactive analogue kn 92 phosphate - by Bioz Stars, 2026-04
    94/100 stars

    Images



    Similar Products

    inactive analogue kn 92 phosphate  (MedChemExpress)
    94
    MedChemExpress inactive analogue kn 92 phosphate
    Inactive Analogue Kn 92 Phosphate, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/inactive analogue kn 92 phosphate/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    inactive analogue kn 92 phosphate - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    kn92  (Selleck Chemicals)
    93
    Selleck Chemicals kn92
    Kn92, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kn92/product/Selleck Chemicals
    Average 93 stars, based on 1 article reviews
    kn92 - by Bioz Stars, 2026-04
    93/100 stars
    		  Buy from Supplier
    kn92  (Tocris)
    93
    Tocris kn92
    A. Left: Representative REST immunoblots of primary cortical neurons (DIV14) treated with the cell-permeable competitive Ca 2+ -calmodulin antagonist W7 (20 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities. **p=0.0071; unpaired Student’s t -test (n=5 independent neuronal preparations). B. Left: Representative REST immunoblots of DIV 14 primary cortical neurons treated with the phosphatase inhibitor cyclosporin A (CsA; 1 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST expression shown as a ratio between REST and calnexin immunoreactivities. p=0.36; unpaired Student’s t -test (n=5 independent neuronal preparations). C. Left: Representative REST immunoblots of DIV14 primary cortical neurons treated with vehicle (Ctrl), the cell-permeable CaMK inhibitor KN93 (10 µM), or its inactive derivative <t>KN92</t> (10 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities for the three treatments. *p=0.031, Ctrl vs KN93; *p=0.032, KN93 vs KN92; one-way ANOVA/Holm-Sidak’s tests (n=5 independent neuronal preparations).
    Kn92, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kn92/product/Tocris
    Average 93 stars, based on 1 article reviews
    kn92 - by Bioz Stars, 2026-04
    93/100 stars
    		  Buy from Supplier
    kn 92  (MedChemExpress)
    94
    MedChemExpress kn 92
    A. Left: Representative REST immunoblots of primary cortical neurons (DIV14) treated with the cell-permeable competitive Ca 2+ -calmodulin antagonist W7 (20 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities. **p=0.0071; unpaired Student’s t -test (n=5 independent neuronal preparations). B. Left: Representative REST immunoblots of DIV 14 primary cortical neurons treated with the phosphatase inhibitor cyclosporin A (CsA; 1 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST expression shown as a ratio between REST and calnexin immunoreactivities. p=0.36; unpaired Student’s t -test (n=5 independent neuronal preparations). C. Left: Representative REST immunoblots of DIV14 primary cortical neurons treated with vehicle (Ctrl), the cell-permeable CaMK inhibitor KN93 (10 µM), or its inactive derivative <t>KN92</t> (10 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities for the three treatments. *p=0.031, Ctrl vs KN93; *p=0.032, KN93 vs KN92; one-way ANOVA/Holm-Sidak’s tests (n=5 independent neuronal preparations).
    Kn 92, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kn 92/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    kn 92 - by Bioz Stars, 2026-04
    94/100 stars
    		  Buy from Supplier
    kn-92  (Millipore)
    90
    Millipore kn-92
    A. Left: Representative REST immunoblots of primary cortical neurons (DIV14) treated with the cell-permeable competitive Ca 2+ -calmodulin antagonist W7 (20 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities. **p=0.0071; unpaired Student’s t -test (n=5 independent neuronal preparations). B. Left: Representative REST immunoblots of DIV 14 primary cortical neurons treated with the phosphatase inhibitor cyclosporin A (CsA; 1 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST expression shown as a ratio between REST and calnexin immunoreactivities. p=0.36; unpaired Student’s t -test (n=5 independent neuronal preparations). C. Left: Representative REST immunoblots of DIV14 primary cortical neurons treated with vehicle (Ctrl), the cell-permeable CaMK inhibitor KN93 (10 µM), or its inactive derivative <t>KN92</t> (10 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities for the three treatments. *p=0.031, Ctrl vs KN93; *p=0.032, KN93 vs KN92; one-way ANOVA/Holm-Sidak’s tests (n=5 independent neuronal preparations).
    Kn 92, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/kn-92/product/Millipore
    Average 90 stars, based on 1 article reviews
    kn-92 - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier
    palmitate miliporesigma  (MedChemExpress)
    90
    MedChemExpress palmitate miliporesigma
    A. Left: Representative REST immunoblots of primary cortical neurons (DIV14) treated with the cell-permeable competitive Ca 2+ -calmodulin antagonist W7 (20 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities. **p=0.0071; unpaired Student’s t -test (n=5 independent neuronal preparations). B. Left: Representative REST immunoblots of DIV 14 primary cortical neurons treated with the phosphatase inhibitor cyclosporin A (CsA; 1 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST expression shown as a ratio between REST and calnexin immunoreactivities. p=0.36; unpaired Student’s t -test (n=5 independent neuronal preparations). C. Left: Representative REST immunoblots of DIV14 primary cortical neurons treated with vehicle (Ctrl), the cell-permeable CaMK inhibitor KN93 (10 µM), or its inactive derivative <t>KN92</t> (10 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities for the three treatments. *p=0.031, Ctrl vs KN93; *p=0.032, KN93 vs KN92; one-way ANOVA/Holm-Sidak’s tests (n=5 independent neuronal preparations).
    Palmitate Miliporesigma, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/palmitate miliporesigma/product/MedChemExpress
    Average 90 stars, based on 1 article reviews
    palmitate miliporesigma - by Bioz Stars, 2026-04
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    A. Left: Representative REST immunoblots of primary cortical neurons (DIV14) treated with the cell-permeable competitive Ca 2+ -calmodulin antagonist W7 (20 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities. **p=0.0071; unpaired Student’s t -test (n=5 independent neuronal preparations). B. Left: Representative REST immunoblots of DIV 14 primary cortical neurons treated with the phosphatase inhibitor cyclosporin A (CsA; 1 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST expression shown as a ratio between REST and calnexin immunoreactivities. p=0.36; unpaired Student’s t -test (n=5 independent neuronal preparations). C. Left: Representative REST immunoblots of DIV14 primary cortical neurons treated with vehicle (Ctrl), the cell-permeable CaMK inhibitor KN93 (10 µM), or its inactive derivative KN92 (10 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities for the three treatments. *p=0.031, Ctrl vs KN93; *p=0.032, KN93 vs KN92; one-way ANOVA/Holm-Sidak’s tests (n=5 independent neuronal preparations).

    Journal: bioRxiv

    Article Title: REST/NRSF phosphorylation by CaMKIV regulates its transcriptional repressor activity and half-life

    doi: 10.1101/2025.09.04.674163

    Figure Lengend Snippet: A. Left: Representative REST immunoblots of primary cortical neurons (DIV14) treated with the cell-permeable competitive Ca 2+ -calmodulin antagonist W7 (20 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities. **p=0.0071; unpaired Student’s t -test (n=5 independent neuronal preparations). B. Left: Representative REST immunoblots of DIV 14 primary cortical neurons treated with the phosphatase inhibitor cyclosporin A (CsA; 1 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST expression shown as a ratio between REST and calnexin immunoreactivities. p=0.36; unpaired Student’s t -test (n=5 independent neuronal preparations). C. Left: Representative REST immunoblots of DIV14 primary cortical neurons treated with vehicle (Ctrl), the cell-permeable CaMK inhibitor KN93 (10 µM), or its inactive derivative KN92 (10 µM). Calnexin was used as a control for equal loading. Right: Mean (± sem with individual experimental points) REST protein expression shown as a ratio between REST and calnexin immunoreactivities for the three treatments. *p=0.031, Ctrl vs KN93; *p=0.032, KN93 vs KN92; one-way ANOVA/Holm-Sidak’s tests (n=5 independent neuronal preparations).

    Article Snippet: W7 (N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride), KN92, KN93, bicuculline, CGP58845, D-APV, and tetrodotoxin were from Tocris (Bristol, UK).

    Techniques: Western Blot, Control, Expressing